Comparing two ways to stimulate the brain for Parkinson's
Part of Brain & nervous system clinical trials.
This trial compares two methods of deep brain stimulation (constant current vs constant voltage) for people with Parkinson's who already have the device placed but haven't turned it on yet. The goal is to see which method works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease that is not caused by another condition
- You are between 18 and 75 years old
- You have already had the deep brain stimulation surgery (electrodes placed), but the device has not been turned on yet
- You do not have a mental disorder or dementia
- You are not pregnant, breastfeeding, or planning to become pregnant
- You do not have serious health problems like cancer, liver or kidney disease, epilepsy, or seizures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two brain targets for deep brain stimulation to see which helps Parkinson's symptoms more. It tests if placing the device in the subthalamic nucleus or the globus pallidus internus gives better results.
This study tests whether stimulating specific parts of the brain's subthalamic nucleus at different frequencies can improve control over unwanted movements or impulses in people with Parkinson's disease. If you are planning to have DBS surgery, this trial may help find a better way to use the device.
This trial studies how deep brain stimulation (DBS) works and can help control Parkinson's symptoms. It uses a special DBS device that is safe for MRI scans.
This trial looks at how two different brain stimulation targets—the subthalamic nucleus (STN) and the ventral intermediate nucleus (VIM)—affect the amount of Parkinson's medication needed one year after surgery. It may help identify which stimulation site leads to a better reduction in medication.
This trial compares two ways of programming deep brain stimulation (DBS) devices for Parkinson's disease. One method uses brain wave measurements to guide settings, while the other uses standard clinical testing. The goal is to see which approach works better for controlling symptoms.
This study looks at how deep brain stimulation (DBS) in a part of the brain called the subthalamic nucleus affects Parkinson's disease. It aims to understand the biological changes that happen with this treatment.
Hear when a new Parkinson's Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.